Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics
CE Demeure, O Dussurget, G Mas Fiol… - Genes & …, 2019 - nature.com
Plague is a vector-borne disease caused by Yersinia pestis. Transmitted by fleas from
rodent reservoirs, Y. pestis emerged< 6000 years ago from an enteric bacterial ancestor …
rodent reservoirs, Y. pestis emerged< 6000 years ago from an enteric bacterial ancestor …
Advances in aquaculture vaccines against fish pathogens: global status and current trends
In recent years, aquaculture has attained a major economic revolution, however, infectious
diseases of bacterial, viral, mycotic and parasitic origin are the most significant restrictive …
diseases of bacterial, viral, mycotic and parasitic origin are the most significant restrictive …
Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine
DG Heath, GW Anderson Jr, JM Mauro, SL Welkos… - Vaccine, 1998 - Elsevier
The current human whole-cell vaccine is ineffective against pneumonic plague caused by
typical F1 capsule positive (F1+) strains of Yersinia pestis. The authors found this vaccine to …
typical F1 capsule positive (F1+) strains of Yersinia pestis. The authors found this vaccine to …
The type III secretion system tip complex and translocon
CA Mueller, P Broz, GR Cornelis - Molecular microbiology, 2008 - Wiley Online Library
The type III secretion machinery of Gram‐negative bacteria, also known as the injectisome
or needle complex, is composed of a basal body spanning both bacterial membranes and …
or needle complex, is composed of a basal body spanning both bacterial membranes and …
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and-negative strains of Yersinia pestis
GW Anderson Jr, SE Leary, ED Williamson… - Infection and …, 1996 - Am Soc Microbiol
The purified recombinant V antigen from Yersinia pestis, expressed in Escherichia coli and
adsorbed to aluminum hydroxide, an adjuvant approved for human use, was used to …
adsorbed to aluminum hydroxide, an adjuvant approved for human use, was used to …
Vaccination against bubonic and pneumonic plague
RW Titball, ED Williamson - Vaccine, 2001 - Elsevier
Yersinia pestis is the etiological agent of bubonic and pneumonic plague, diseases which
have caused over 200 milllion human deaths in the past. Plague still occurs throughout the …
have caused over 200 milllion human deaths in the past. Plague still occurs throughout the …
Human immune response to a plague vaccine comprising recombinant F1 and V antigens
ED Williamson, HC Flick-Smith, C Lebutt… - Infection and …, 2005 - Am Soc Microbiol
The human immune response to a new recombinant plague vaccine, comprising
recombinant F1 (rF1) and rV antigens, has been assessed during a phase 1 safety and …
recombinant F1 (rF1) and rV antigens, has been assessed during a phase 1 safety and …
Current challenges in the development of vaccines for pneumonic plague
ST Smiley - Expert review of vaccines, 2008 - Taylor & Francis
Inhalation of Yersinia pestis bacilli causes pneumonic plague, a rapidly progressing and
exceptionally virulent disease. Extensively antibiotic-resistant Y. pestis strains exist and we …
exceptionally virulent disease. Extensively antibiotic-resistant Y. pestis strains exist and we …
A bacteriophage T4 nanoparticle-based dual vaccine against anthrax and plague
Bacillus anthracis and Yersinia pestis, the causative agents of anthrax and plague,
respectively, are two of the deadliest pathogenic bacteria that have been used as biological …
respectively, are two of the deadliest pathogenic bacteria that have been used as biological …
Cell-Mediated Protection against Pulmonary Yersinia pestis Infection
MA Parent, KN Berggren, LW Kummer… - Infection and …, 2005 - Am Soc Microbiol
Pulmonary infection with the bacterium Yersinia pestis causes pneumonic plague, an often-
fatal disease for which no vaccine is presently available. Antibody-mediated humoral …
fatal disease for which no vaccine is presently available. Antibody-mediated humoral …